期刊
AMERICAN JOURNAL OF PATHOLOGY
卷 182, 期 2, 页码 375-387出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.ajpath.2012.10.014
关键词
-
类别
资金
- Veterans Affairs (VA) Merit Review grant from VA Research Service
- National Institute of Diabetes and Digestive and Kidney Diseases [RO 1-DK-64165-01, RO 1-DK-081429]
- NCI [P30 CA118100]
- NCRR [1S10RR025540]
- NIDDK [3R301 DK050141]
- NIGMS [P50 GM085273]
Bacterial-derived Lipopolysaccharides (LPS) play an essential role in the inflammatory process of inflammatory bowel disease. A defective intestinal tight junction (TJ) barrier is an important pathogenic factor of inflammatory bowel disease and other inflammatory conditions of the gut. Despite its importance in mediating intestinal inflammation, the physiological effects of LPS on the intestinal epithelial barrier remain unclear. The major aims of this study were to determine the effects of physiologically relevant concentrations of LPS (0 to 1 ng/mL) on intestinal barrier function using an in vitro (filter-grown Caco-2 monolayers) and an in vivo (mouse intestinal perfusion) intestinal epithelial model system. LPS, at physiologically relevant concentrations (0 to 1 ng/mL), in the basolateral compartment produced a time-dependent increase in Caco-2 TJ permeability without inducing cell death. Intraperitoneal injection of LPS (0.1 mg/kg), leading to clinically relevant plasma concentrations, also caused a time-dependent increase in intestinal permeability in vivo. The LPS-induced increase in intestinal TJ permeability was mediated by an increase in enterocyte membrane TLR-4 expression and a TLR-4-dependent increase in membrane colocalization of membrane-associated protein CD14. In conclusion, these studies show for the first time that LPS causes an increase in intestinal permeability via an intracellular mechanism involving TLR-4 dependent up-regulation of CD14 membrane expression. (Am J Pathol 2013, 182:375-387; http://dx.doi.org/10.1016/j.ajpath.2012.10.014)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据